| Financial Year |
March 31 2023 |
| Monetary Funds |
310,359,062.97 |
| Held-for-trading Financial Assets |
234,641,361.98 |
| Notes Receivable |
19,022,112.70 |
| Accounts Receivable |
375,167,305.27 |
| Advances to Suppliers |
17,070,625.45 |
| Other Receivables |
16,415,859.36 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
163,819,479.28 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
5,324,005.95 |
| Total Current Assets |
1,141,819,812.96 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
239,200,138.50 |
| Under-construction Projects |
1,192,660.55 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
98,985,603.57 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
2,553,949.41 |
| Other Non-Current Assets |
21,804,795.00 |
| Sub-Total of Non-Current Assets |
373,168,228.29 |
| Total Assets |
1,514,988,041.25 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
1,476,676.32 |
| Notes Payable |
91,825,000.00 |
| Accounts Payable |
308,240,929.62 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
20,432,894.89 |
| Taxes Payable |
6,055,581.69 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
143,634.25 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,700,267.40 |
| Other Current Liabilities |
19,308,116.48 |
| Sub-Total of Current Liabilities |
458,977,274.62 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
12,668,119.31 |
| Total Liabilities |
471,645,393.93 |
| Paid-In Capital(Or Share Stock) |
186,660,000.00 |
| Capital Surplus |
478,672,100.00 |
| Surplus Reserve |
40,383,346.24 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
337,627,201.08 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,043,342,647.32 |
| Owner's Equity（Stockholder's Equity） |
1,043,342,647.32 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,514,988,041.25 |
